> top > docs > PMC:3359311 > spans > 28385-28576 > annotations

PMC:3359311 / 28385-28576 JSONTXT

Annnotations TAB JSON ListView MergeView

UBERON-AE

Id Subject Object Predicate Lexical cue
T10410 59-64 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T10662 0-3 DT denotes All
T10663 4-12 NNS denotes patients
T10664 13-17 IN denotes with
T10665 18-20 NNP denotes CF
T10666 21-25 VBD denotes were
T10667 26-36 RB denotes clinically
T10668 37-43 JJ denotes stable
T10669 44-46 IN denotes at
T10670 47-50 DT denotes the
T10671 51-55 NN denotes time
T10672 56-58 IN denotes of
T10673 59-64 NN denotes blood
T10674 65-73 NN denotes donation
T10675 73-74 , denotes ,
T10676 75-78 CC denotes and
T10677 79-81 PRP denotes we
T10678 82-90 VBD denotes excluded
T10679 91-94 DT denotes any
T10680 95-103 NNS denotes subjects
T10681 104-107 WP denotes who
T10682 108-112 VBD denotes were
T10683 113-122 VBG denotes receiving
T10684 123-131 JJ denotes systemic
T10685 132-147 NNS denotes corticosteroids
T10686 148-151 JJ denotes due
T10687 152-154 TO denotes to
T10688 155-164 JJ denotes potential
T10689 165-181 JJ denotes immunomodulatory
T10690 182-190 NN denotes activity
T10691 190-191 . denotes .
R9380 T10662 T10663 det All,patients
R9381 T10663 T10666 nsubj patients,were
R9382 T10664 T10663 prep with,patients
R9383 T10665 T10664 pobj CF,with
R9384 T10666 T10666 ROOT were,were
R9385 T10667 T10668 advmod clinically,stable
R9386 T10668 T10666 acomp stable,were
R9387 T10669 T10666 prep at,were
R9388 T10670 T10671 det the,time
R9389 T10671 T10669 pobj time,at
R9390 T10672 T10671 prep of,time
R9391 T10673 T10674 compound blood,donation
R9392 T10674 T10672 pobj donation,of
R9393 T10675 T10666 punct ",",were
R9394 T10676 T10666 cc and,were
R9395 T10677 T10678 nsubj we,excluded
R9396 T10678 T10666 conj excluded,were
R9397 T10679 T10680 det any,subjects
R9398 T10680 T10678 dobj subjects,excluded
R9399 T10681 T10683 nsubj who,receiving
R9400 T10682 T10683 aux were,receiving
R9401 T10683 T10680 relcl receiving,subjects
R9402 T10684 T10685 amod systemic,corticosteroids
R9403 T10685 T10683 dobj corticosteroids,receiving
R9404 T10686 T10680 amod due,subjects
R9405 T10687 T10686 prep to,due
R9406 T10688 T10690 amod potential,activity
R9407 T10689 T10690 amod immunomodulatory,activity
R9408 T10690 T10687 pobj activity,to
R9409 T10691 T10678 punct .,excluded

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T10455 0-3 DT denotes All
T10456 4-12 NN denotes patients
T10457 13-17 IN denotes with
T10458 18-20 NN denotes CF
T10459 21-25 VB denotes were
T10460 26-36 RB denotes clinically
T10461 37-43 JJ denotes stable
T10462 44-46 IN denotes at
T10463 47-50 DT denotes the
T10464 51-55 NN denotes time
T10465 56-58 IN denotes of
T10466 59-64 NN denotes blood
T10467 65-73 NN denotes donation
T10468 73-74 -COMMA- denotes ,
T10469 75-78 CC denotes and
T10470 79-81 PRP denotes we
T10471 82-90 VB denotes excluded
T10472 91-94 DT denotes any
T10473 95-103 NN denotes subjects
T10474 104-107 WP denotes who
T10475 108-112 VB denotes were
T10476 113-122 VB denotes receiving
T10477 123-131 JJ denotes systemic
T10478 132-147 NN denotes corticosteroids
T10479 148-151 JJ denotes due
T10480 152-154 TO denotes to
T10481 155-164 JJ denotes potential
T10482 165-181 JJ denotes immunomodulatory
T10483 182-190 NN denotes activity
R9163 T10456 T10455 arg1Of patients,All
R9164 T10456 T10457 arg1Of patients,with
R9165 T10456 T10459 arg1Of patients,were
R9166 T10456 T10461 arg1Of patients,stable
R9167 T10458 T10457 arg2Of CF,with
R9168 T10459 T10469 arg1Of were,and
R9169 T10461 T10459 arg2Of stable,were
R9170 T10461 T10460 arg1Of stable,clinically
R9171 T10461 T10462 arg1Of stable,at
R9172 T10464 T10462 arg2Of time,at
R9173 T10464 T10463 arg1Of time,the
R9174 T10464 T10465 arg1Of time,of
R9175 T10467 T10465 arg2Of donation,of
R9176 T10467 T10466 arg1Of donation,blood
R9177 T10469 T10468 arg1Of and,","
R9178 T10470 T10471 arg1Of we,excluded
R9179 T10471 T10469 arg2Of excluded,and
R9180 T10473 T10471 arg2Of subjects,excluded
R9181 T10473 T10472 arg1Of subjects,any
R9182 T10473 T10474 arg1Of subjects,who
R9183 T10473 T10475 arg1Of subjects,were
R9184 T10473 T10476 arg1Of subjects,receiving
R9185 T10476 T10475 arg2Of receiving,were
R9186 T10478 T10476 arg2Of corticosteroids,receiving
R9187 T10478 T10477 arg1Of corticosteroids,systemic
R9188 T10478 T10479 arg1Of corticosteroids,due
R9189 T10479 T10480 arg1Of due,to
R9190 T10483 T10480 arg2Of activity,to
R9191 T10483 T10481 arg1Of activity,potential
R9192 T10483 T10482 arg1Of activity,immunomodulatory

sentences

Id Subject Object Predicate Lexical cue
T10416 0-191 Sentence denotes All patients with CF were clinically stable at the time of blood donation, and we excluded any subjects who were receiving systemic corticosteroids due to potential immunomodulatory activity.
T190 0-191 Sentence denotes All patients with CF were clinically stable at the time of blood donation, and we excluded any subjects who were receiving systemic corticosteroids due to potential immunomodulatory activity.